Skip to main content
. 2023 Jan 31;21:1236–1248. doi: 10.1016/j.csbj.2023.01.041

Fig. 3.

Fig. 3

Docking pose of (A) GLYAT and benzoyl-CoA/glycine, (B) GLYAT and isovaleryl-CoA/ glycine, (C) GLYAT and isovaleryl-CoA/glutamine, (D) GLYATL1 and phenylacetyl-CoA/ glutamine and (E) GLYATL1 and phenylacetyl-CoA/glycine, (F) GLYATL1 and isovaleryl-CoA/glycine and (G) GLYATL1 and isovaleryl-CoA/glutamine.